MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.660
-0.090
-5.14%
Opening 13:24 05/28 EDT
OPEN
1.760
PREV CLOSE
1.750
HIGH
1.790
LOW
1.620
VOLUME
3.80M
TURNOVER
0
52 WEEK HIGH
2.105
52 WEEK LOW
0.3450
MARKET CAP
427.16M
P/E (TTM)
-7.0698
1D
5D
1M
3M
1Y
5Y
Ocugen set to join Russell 3000 Index
Ocugen set to join Russell 3000 Index May 28, 2024. The newly reconstructed index will take effect after the market closes on June 28,. 2024. Ocugen said it will be included in the Russell 3000 index, according to preliminary Russell reconstruction information. The company's stock will be listed on Nasdaq.
Seeking Alpha · 6h ago
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
Ocugen, Inc. Is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines. The newly reconstructed index will take effect after the market closes on June 28, 2024. Ocugen is expected to be included in the Russell 3000 Index.
Barchart · 11h ago
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
Ocugen, Inc. Investors have until June 10, 2024 to file a lead plaintiff motion. On April 1, 2024, Ocugen disclosed that it had identified certain accounting errors. The Company’s stock price fell $. On April 2, 2024. The class action lawsuit has been filed on behalf of investors.
Barchart · 1d ago
Weekly Report: what happened at OCGN last week (0520-0524)?
Weekly Report · 1d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
Ocugen, Inc. Investors have until June 10, 2024 to file a lead plaintiff motion. On April 1, 2024, Ocugen disclosed that it had identified certain accounting errors. The Company’s stock price fell $ to close at $2 per share on April 2, 2024.
Barchart · 6d ago
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
Investors who purchased Ocugen, Inc. Securities between May 8, 2020 and April 1, 2024 have until June 10, 2024 to file a class action lawsuit. Law Offices of Howard G. Smith says the Company made false and misleading statements to investors. The Company’s stock price fell $ on April 2, 2024.
Barchart · 05/21 17:12
Weekly Report: what happened at OCGN last week (0513-0517)?
Weekly Report · 05/20 10:20
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
Ocugen, Inc. Is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines. Arun Upadhyay, PhD, will speak at the International Society for Cell & Gene Therapy Annual Meeting in Vancouver, Canada.
Barchart · 05/20 06:00
More
About OCGN
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.